MT1 and MT2 melatonin receptors — Drug Target

12 drugs 10 marketed 2 in Phase 3

All drugs that target MT1 and MT2 melatonin receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Melatonin receptor agonist

Marketed (10)

Phase 3 pipeline (2)